Promoting access to medical abortion in the context of safe abortion worldwide… Rodica Comendant MD, PhD, ICMA Coordinator ICMA Coordinator ICMA – Ipas.

Slides:



Advertisements
Similar presentations
Making the Right Decisions for the Health of Girls and Women Ruth Levine, PhD.
Advertisements

Reducing inequalities: Enhancing young people’s access to SRHR Consultative meeting with African Parliamentarians on ICPD and MDGs September 2012 Sharon.
Motivating for national circumcision policy. Global prevalence of MC.
Safe abortion- medical methods of termination, post abortion care and referral, pre and post abortion counseling 27/06/2014.
Strengthen access to comprehensive SRHR services, with specific focus on family planning services Dr Miriam Chipimo – Senior Policy & Programme Adviser,
ADDING IT UP The costs and benefits of investing in family planning and maternal and newborn health.
Maternal Survival in Afghanistan: Progress and Challenges Mary Ellen Stanton Senior Maternal Health Advisor Bureau for Global Health, USAID Health in Afghanistan:
Pro-Choice Eric Andrews and Paul Davidsen. History In 1973, the Supreme Court guaranteed American women the right to choose abortion in In 1973, the Supreme.
Understanding Maternal Death Reviews MDR Workshop Lucknow India June 17-18, 2010.
Building the Foundations for Better Health Health Services Organization.
1 Adolescent Reproductive Health Presented by: Dr. Richard O. Muga (MBS) National Co-ordinating Agency for Population and Development, Nairobi- Kenya Seminar.
Factors Affecting Maternal Mortality (MM) in Turkey and in the World Dr. Yeşim YASİN Spring-2014.
A Presentation to __________ Healthy Timing and Spacing of Pregnancy (HTSP): For healthy babies, healthy mothers, and healthy communities.
Induced Abortion: Incidence and Trends Worldwide 1995 to 2008 Presented by Gilda Sedgh Guttmacher Institute January 18, 2012.
UNWANTED PREGNANCY.
Induced Abortion: Incidence and Trends Worldwide 1995 to 2008 Gilda Sedgh Guttmacher Institute April 2012.
Using hotlines to improve women’s access to information in legally restricted settings Líneas telefónicas sobre misoprostol para un aborto seguro: mejorando.
Abortion in Africa Marijke Alblas, Medical Consultant, S.A.
Abortion: A Controversial Issue. What is it? Abortion is the act of purposely removing a human embryo or fetus from its mother’s uterus before it is capable.
Unsafe Abortion Dr Reza Nasr MD MRCOG DFFP NAIGO Monthly Meeting
Towards Equity and Rights: South Asian Partnerships for Reducing Maternal Mortality.
“Who does provide services; and where? ” France: How we are moving medical abortion services away from hospital based Expanding Access to Medical Abortion:
Critical Role of ICT in Parliament Fulfill legislative, oversight, and representative responsibilities Achieve the goals of transparency, openness, accessibility,
Modernising Abortion Services……………. Nurse/Midwife Led Provision Alison Jones, Consultant Nurse Sexual Health & Teenage Pregnancy Pontypridd & Rhondda NHS.
Latin American Consortium Against Unsafe Abortion Who we are; current activities and future priorities Lisboa, Portugal, March 2 – 4, 2010.
Health Promoting Health Service: Development day.
International Consortium for Medical Abortion Who we are StructureActivitiesVision.
Reproductive rights of women seeking abortion Galina Maistruk, Сoordinator European Alliance for Reproductive Choice.
Integrating medical abortion into safe abortion services in South Africa Jennifer Moodley Margaret Hoffman.
Medical abortion with mifepristone and misoprostol: overview
Child and Adolescent Health and Development RHR RHR Guidance of WHO on safe abortion FIAPAC, Moscow October 28, 2005 G. Lazdane Regional Adviser RHR WHO.
04 March, 2010 Lisbon. Date of Establishment: March 2009, Joberg,S.A Founding members: 54 participants from 20 African countries + 7 other partners from.
ABORTION (SITUATIONAL ANALISIS) REPUBLIC of MOLDOVA Dr. Rodica Comendant, National coordinator FIGO WORKING GRUP ON UNSAFE ABORTION.
Public-Private Partnerships -Selected Experiences in the Western Pacific & Cambodia- National Forum on Public-Private Partnership in Health 7 November,
05_XXX_MM1 Implementing Safe Abortion: technical and policy guidance for health systems Ronnie Johnson, PhD UNDP/UNFPA/WHO/World Bank Special Programme.
ICMA conference “Using hotlines to improve women’s access to information in legally restricted settings” Women on Web – Acceptability and Regional rates.
Dr Joachim Osur MISOPROSTOL AT GRASSROOTS. Drug Availability Misoprostol is registered for PUD in almost all countries. As a result not strictly controlled.
COMPREHENSIVE ABORTION CARE MISOPROSTOL TO IMPROVE CLIENT ACCESS & CHOICE FOR POST-ABORTION CARE IN NOWSHERA DISTRICT, KP PROVINCE, PAKISTAN Dr. Syed Rizwan.
Expanding access to medical abortion Marge Berer Editor, Reproductive Health Matters Chair, ICMA Steering Committee *** Lisbon, March 2010.
Misoprostol for PAC Task Force Presentations PAC Consortium Meeting May 26, 2009.
Second trimester abortion: law, policy, service delivery and advocacy issues. Overview of the discussions and recommendations from ICMA Conference on second.
 Identify current issues in both IL and AL  Review benefits of IL and AL and interaction with home support/care services  Recommend actions to support,
21 JUNE 2006 Zimbabwe AIDS Network Presentation ” TAG/TAC AFRICA REGION TB/HIV ADVOCACY WORKSHOP PRESENTATION BY DOMINICA MUDOTA.
From choice, a world of possibilities SRHR/ IPPF Resources Regional Council Sarajevo 28 June 2014.
Mosotho Gabriel: Program Director Ipas Africa Alliance for Women’s Reproductive Health and Right ICMA Meeting: 11 March 2008, Johannesburg, South Africa.
Challenges and Perspectives in Advocacy for Safe Abortion FIAPAC 9 th Congress Seville 2010 Daniela Draghici Steering Committee member.
Volservnet Voluntary Services and Networking A project in collaboration with the Ministry of Health, the Elderly and Community Care.
Implementation of WHO Guidance in Moldova Rodica Comendant, MD, RHTC Director IX FIAPAC Conference, Spain Seville, October 2010, With thanks to the colleagues.
The Eastern European Alliance for Reproductive Choice (EEARC) was established in June 2008 thanks to support of ICMA and representatives from 11 countries,
Medical Abortion in Ethiopia: Policy and Practice Africa Regional Meeting on Medical Abortion Johannesburg, South Africa March 11-13rd,2009.
Abortion. Options counseling Lucy presents to your office for an annual exam and when you take the menstrual history, she reports that her last period.
Making childbirth safer: Promoting Evidence-based Care Name of presenter Prevention of Postpartum Hemorrhage Initiative (POPPHI) Project.
 An abortion is the termination of a pregnancy by the removal or expulsion of an embryo or fetus from the uterus, resulting in or caused by its death.
West Balkans Regional EEA/Eionet Cooperation Expert Workshop on Biodiversity Indicators Tirana  4 June 2013 Jennifer Emond, UNEP Brussels Outcomes of.
Asia Safe Abortion Partnership
Reproductive Health class#2 Safe motherhood. Women’s Health Key facts.
Developing an African Network on Medical Abortion Johannesburg, South Africa March 2009.
Misoprostol: Challenging restrictive Laws & faiths in rural Tanzania WPC’s Experience Addressing Women’s Abortion Need in Rural Communities.
1 Background & history of the debate Geneva, 14 October 2009 Ralf Jürgens.
Existing African networks on abortion Mosotho Gabriel, Program Director Ipas Africa Alliance, for Women’s Reproductive Health and Right ICMA Meeting; March.
Asia Safe Abortion Partnership ASAP. Who we are ………. ASAP came into existence in March 2008 at the initiative of ICMA, when 37 participants from 13 countries.
1 Role of family planning in reducing unwanted pregnancies and unsafe abortions: synthesis of global and Kenya specific evidence Violet I. Murunga and.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
Improving Access to Safe Abortion Guidance on Making High-Quality Services Accessible Based on Safe Abortion: Technical and Policy Guidance for Health.
Recommended Uterine Evacuation Methods
Maternal Mortality Assistant Professor Dr. Batool A. Gh. Yassin Depart. Of Community & family Medicine Baghdad College of Medicine 2014.
Determinants of Induced Abortion Among Youth Seeking Reproductive Health Care in Addis Ababa, Ethiopia Bisrat Fantaye, B. Pharm, MPH IAWG 16 th annual.
Medical Abortion at all Gestations
GSRHR course 2010 The Three Delays Model Pauline Binder, PhD student
Geneva 2019 SAFE ABORTION CARE Dr Venkatraman Chandra-Mouli.
Presentation transcript:

Promoting access to medical abortion in the context of safe abortion worldwide… Rodica Comendant MD, PhD, ICMA Coordinator ICMA Coordinator ICMA – Ipas Meeting “Developing an African network on safe/medical abortion” March, 2009, Johannesburg, SA

Safe abortion services are essential for women Unsafe abortions are a major public health problem. Unsafe abortions are a major public health problem. Of 210 million pregnancies yearly, an estimated 46 million end in induced abortion. Of 210 million pregnancies yearly, an estimated 46 million end in induced abortion. Of the estimated 19 million unsafe abortions in the world each year, 18.5 million occur in developing countries. Of the estimated 19 million unsafe abortions in the world each year, 18.5 million occur in developing countries. About women die each year from unsafe abortion. About women die each year from unsafe abortion. Abortion-related complications cause up to 50% of obstetrical-gynaecological hospital admissions for women in some developing countries. Abortion-related complications cause up to 50% of obstetrical-gynaecological hospital admissions for women in some developing countries.

Safe abortion services are essential for women  Young and unmarried women are often afraid to tell anyone they are pregnant and are more likely to seek terminations from unqualified practitioners.  They account for a disproportionate share of death and illness from the complications of dangerous abortions.

What is medical abortion? “Medical abortion” is the use of drugs to terminate a pregnancy. It is sometimes also called non-surgical abortion. “Medical abortion” is the use of drugs to terminate a pregnancy. It is sometimes also called non-surgical abortion. The regimen for first trimester medical abortion, registered in more than 35 countries, consists of two drugs, included in 2005 on the WHO Essential Medicines list: The regimen for first trimester medical abortion, registered in more than 35 countries, consists of two drugs, included in 2005 on the WHO Essential Medicines list: mifepristone (an anti-progestogen that blocks progesterone, the hormone necessary to sustain a pregnancy), followed 1–3 days later by misoprostol (a prostaglandin that makes the uterus contract). mifepristone (an anti-progestogen that blocks progesterone, the hormone necessary to sustain a pregnancy), followed 1–3 days later by misoprostol (a prostaglandin that makes the uterus contract). These drugs can be taken to cause a miscarriage to occur, starting from the time a woman misses her period. These drugs can be taken to cause a miscarriage to occur, starting from the time a woman misses her period. Where mifepristone is not available, misoprostol can be used alone to cause the miscarriage. Where mifepristone is not available, misoprostol can be used alone to cause the miscarriage.

WHO: Safe Abortion: Technical and Policy Guidance for Health Systems, 2004 Methods of abortion

Why medical abortion is important? Medical abortion can make abortion:  earlier,  more accessible,  safer,  less traumatic,  less medicalised and less expensive.  It has increased access to safe abortion and reduced maternal mortality, including in legally restricted settings.

Why medical abortion is important?  Medical abortion has been shown to be safe and effective in both the first and second trimesters of pregnancy, with efficacy rates as high as 95  98%.  Acceptability among women is high, because medical abortion does not involve surgery or anaesthesia, and is a simple procedure that happens entirely in the woman’s body.  Acceptability among providers is high too, because they feel that it is safe and offers women an alternative to surgical abortion, and is a choice that many women prefer.

ICMA ICMA was formed in June 2002 with the ICMA was formed in June 2002 with the aim: aim: to promote access to medical abortion in the context of support for safe abortion worldwide, focusing on the needs of women in developing countries, especially those where safe abortion is not easily accessible. to promote access to medical abortion in the context of support for safe abortion worldwide, focusing on the needs of women in developing countries, especially those where safe abortion is not easily accessible.

ICMA International non-governmental, non-profit organization International non-governmental, non-profit organization Growing number of international networks: Growing number of international networks: Latin-American network CLACAI established in Latin-American network CLACAI established in Asian network, ASAP, March 2008 Asian network, ASAP, March 2008 Eastern European network, EEARC, May 2008 Eastern European network, EEARC, May 2008 African network, 2009? African network, 2009? SC with the chair and co-chair, WHO observer, coordinator, advisory group, networks liaison officer SC with the chair and co-chair, WHO observer, coordinator, advisory group, networks liaison officer

ICMA Activities: International Conference in SA in Conference accomplishments: The sharing of information on the use of medical abortion internationally, The sharing of information on the use of medical abortion internationally, An analysis of the influence of alternative policies, programmes and services on access to medical abortion in a range of country settings, An analysis of the influence of alternative policies, programmes and services on access to medical abortion in a range of country settings, The identification of strategies for improving women's access to medical abortion, in the context of safe abortion, with a focus on developing countries and countries in transition, The identification of strategies for improving women's access to medical abortion, in the context of safe abortion, with a focus on developing countries and countries in transition, The creation of a forum for dialogue and networking to broaden the constituency working for medical abortion worldwide. The creation of a forum for dialogue and networking to broaden the constituency working for medical abortion worldwide. The creation of a Consensus Statement advocating for wider availability of medical abortion. The creation of a Consensus Statement advocating for wider availability of medical abortion.

ICMA Activities: Information Package on Medical abortion Comprehensive information package in seven languages that can be adapted and used in many settings, addressed to: Comprehensive information package in seven languages that can be adapted and used in many settings, addressed to: women women health service providers women’s organizations, NGOs policymakers and parliamentarians, and selected recourses on MA. health service providers women’s organizations, NGOs policymakers and parliamentarians, and selected recourses on MA. Available on the web and on CDs Available on the web and on CDs

ICMA Activities: ICMA website, Created in 2003 and expanded and updated in 2007, French, Spanish and Russian sections have been added. Created in 2003 and expanded and updated in 2007, French, Spanish and Russian sections have been added. The site provides up-to-date information on developments and events related to medical abortion worldwide as well as current and upcoming ICMA activities. The site provides up-to-date information on developments and events related to medical abortion worldwide as well as current and upcoming ICMA activities. It has links to references, resources and articles on medical abortion and to the web pages of other organizations working in the same field. It has links to references, resources and articles on medical abortion and to the web pages of other organizations working in the same field.

ICMA Activities: Conference on Second Trimester, London, March 2007 Conference Recommendations: “…access to good quality second trimester services is an essential part of comprehensive safe abortion services. Conference Recommendations: “…access to good quality second trimester services is an essential part of comprehensive safe abortion services. Advocates must work to build support for safe, legal abortion in the second trimester of pregnancy. This work should include: Advocates must work to build support for safe, legal abortion in the second trimester of pregnancy. This work should include: developing better data on the occurrence and need for second trimester abortion, developing better data on the occurrence and need for second trimester abortion, the elimination of legal, regulatory and social barriers to second trimester abortion, the elimination of legal, regulatory and social barriers to second trimester abortion, a commitment of resources to training clinicians to provide later abortions, and a commitment of resources to training clinicians to provide later abortions, and research on the best medical methods in different settings…” research on the best medical methods in different settings…” RHM/ICMA Supplement, based on the conference presentations RHM/ICMA Supplement, based on the conference presentations

ICMA Activities: the third Conference, February Objectives: To share information on the current situation of access to MA in different situations with an emphasis on lessons learned and challenges faced in expanding access. To share information on the current situation of access to MA in different situations with an emphasis on lessons learned and challenges faced in expanding access. To examine strategies that have succeeded in improving access. To examine strategies that have succeeded in improving access. To examine barriers to access and how they have been addressed. To examine barriers to access and how they have been addressed. To discuss issues causing contention within the MA community. To discuss issues causing contention within the MA community.

The outcome at the end of the conference is expected to be a “consensus” statement highlighting strategies and means of expanding access to MA. at the end of the conference is expected to be a “consensus” statement highlighting strategies and means of expanding access to MA. The statement is expected to be used to motivate action at national and local levels. The statement is expected to be used to motivate action at national and local levels.

African network ??? The other regional networks associated with ICMA are independent entities, choose their own staff and steering committees, and develop their own activities. The other regional networks associated with ICMA are independent entities, choose their own staff and steering committees, and develop their own activities. We envisage that any such network in Africa would do the same. We envisage that any such network in Africa would do the same.

ICMA Thank you! Questions…